P. Schein
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Small Animals top 5%
- Animal testing and alternatives
Papers in
-
- Bioactive Compounds and Antitumor Agents 4
-
- Nanoparticle-Based Drug Delivery 4
- Co-authors
- Erik Herman (3 shared papers)Atta ur Rahman (3 shared papers)Victor J. Ferrans (1 shared paper)Vincent T. DeVita (2 shared papers)Stephen K. Carter (1 shared paper)Ruth D. Davis (1 shared paper)David P. Rall (1 shared paper)John W. I. Newman (1 shared paper)
- Journals
- Toxicology and Applied Pharmacology (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Experimental Biology and Medicine (2 papers)The Lancet (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesUgandaFrance
In The Last Decade
P. Schein
18 papers receiving 589 citations
Peers
Comparison fields: 5 of 71
- Biomaterials 141
- Small Animals 84
- Toxicology 51
- Pharmacology 37
- Oncology 70
Countries citing papers authored by P. Schein
This map shows the geographic impact of P. Schein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Schein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Schein more than expected).
Fields of papers citing papers by P. Schein
This network shows the impact of papers produced by P. Schein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Schein. The network helps show where P. Schein may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Schein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1974 | 166 | |
| 2 | Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation. | 1983 | 150 |
| 3 | 1970 | 118 | |
| 4 | 1973 | 90 | |
| 5 | 1986 | 55 | |
| 6 | Animal toxicology for early clinical trials with anticancer agents. | 1981 | 54 |
| 7 | 1978 | 26 | |
| 8 | 1969 | 19 | |
| 9 | 1973 | 17 | |
| 10 | 1976 | 10 | |
| 11 | 1970 | 9 | |
| 12 | 1970 | 5 | |
| 13 | 1972 | 3 | |
| 14 | Toxicity evaluation of doxorubicin entrapped in cardiolipin liposomes in mice. Abstr. | 1983 | 3 |
| 15 | 1984 | 3 | |
| 16 | 1997 | 3 | |
| 17 | 1995 | 2 | |
| 18 | The role of carbamoylation in nitrosourea toxicity and antitumor activity in mice. Abstr. | 1976 | 1 |
| 19 | Protection of chronic cardiotoxicity of adriamycin by liposomal delivery. Abstr. | 1981 | 1 |
| 20 | 1982 | 1 |
About P. Schein
P. Schein is a scholar working on Toxicology, Biomaterials, Small Animals, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 21 papers that have together received 736 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (5 papers), Bioactive Compounds and Antitumor Agents (4 papers), Nanoparticle-Based Drug Delivery (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers), Animal testing and alternatives (3 papers), Carcinogens and Genotoxicity Assessment (2 papers), Acute Myeloid Leukemia Research (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Biomaterials (141 citations), Small Animals (84 citations), Toxicology (51 citations), Pharmacology (37 citations) and Oncology (70 citations). P. Schein has collaborated with scholars based in United States, Uganda and France. Frequent co-authors include Erik Herman, Atta ur Rahman, Victor J. Ferrans, Vincent T. DeVita, Stephen K. Carter, Ruth D. Davis, David P. Rall, John W. I. Newman, I T Magrath and M J O'Connell. Their work appears in journals such as Toxicology and Applied Pharmacology, Cancer Chemotherapy and Pharmacology, Experimental Biology and Medicine, The Lancet and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.